Viewing SEC Facts Units
Company Name:
Qualigen Therapeutics, Inc.
CIK:
1460702
Start Filing Date:
2024-01-01
End Filing Date:
2024-03-31
ACCN:
0001493152-24-025976
Value:
$ 60,017
Value Error:
$ None
Created By:
Date Filed:
2024-07-02
FY:
2024
Fiscal Period:
Q1
Frame:
CY2024Q1
Type:
us-gaap
Form:
10-Q
Units:
USD